Abstract:Here, we present a gene regulation strategy enabling programmable control over eukaryotic translational initiation. By excising the natural poly-adenylation (poly-A) signal of target genes and replacing it with a synthetic control region harboring RNA-binding protein (RBP)-specific aptamers, cap-dependent translation is rendered exclusively dependent on synthetic translation initiation factors (STIFs) containing different RBPs engineered to conditionally associate with different eIF4F-binding proteins (eIFBPs). This modular design framework facilitates the engineering of various gene switches and intracellular sensors responding to many user-defined trigger signals of interest, demonstrating tightly controlled, rapid and reversible regulation of transgene expression in mammalian cells as well as compatibility with various clinically applicable delivery routes of in vivo gene therapy. Therapeutic efficacy was demonstrated in two animal models. To exemplify disease treatments that require on-demand drug secretion, we show that a custom-designed gene switch triggered by the FDA-approved drug grazoprevir can effectively control insulin expression and restore glucose homeostasis in diabetic mice. For diseases that require instantaneous sense-and-response treatment programs, we create highly specific sensors for various subcellularly (mis)localized protein markers (such as cancer-related fusion proteins) and show that translation-based protein sensors can be used either alone or in combination with other cell-state classification strategies to create therapeutic biocomputers driving self-sufficient elimination of tumor cells in mice. This design strategy demonstrates unprecedented flexibility for translational regulation and could form the basis for a novel class of programmable gene therapies in vivo.

Computational identification of small molecules for increased gene expression by synthetic circuits in mammalian cells

Characterization and mitigation of gene expression burden in mammalian cells

A Platform For Rapid Prototyping Of Synthetic Gene Networks In Mammalian Cells

A synthetic transcription platform for programmable gene expression in mammalian cells

Automatic Identification of Small Molecules That Promote Cell Conversion and Reprogramming

Manipulating gene expression levels in mammalian cell factories: An outline of synthetic molecular toolboxes to achieve multiplexed control

Rapid, modular and reliable construction of complex mammalian gene circuits

Clinically-driven design of synthetic gene regulatory programs in human cells

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

miRNA circuit modules for precise, tunable control of gene expression

In-Vivo Real-Time Control of Protein Expression from Endogenous and Synthetic Gene Networks

A synthetic metabolite-based mammalian inter-cell signaling system

Modulating bacterial function utilizing A knowledge base of transcriptional regulatory modules

Engineering Translation in Mammalian Cell Factories to Increase Protein Yield: The Unexpected Use of Long Non-Coding SINEUP RNAs

High-resolution profiling reveals coupled transcriptional and translational regulation of transgenes

Multidimensional control of therapeutic human cell function with synthetic gene circuits

Engineered Genetic Information Processing Circuits

Synthetic Therapeutic Gene Circuits in Mammalian Cells

Small-molecule inducible transcriptional control in mammalian cells

RNAi Expression Tuning, Microfluidic Screening, and Genome Recombineering for Improved Protein Production in Saccharomyces Cerevisiae.

Small-molecule-based regulation of RNA-delivered circuits in mammalian cells